CASI Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.10.21	CASI Pharmaceuticals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And Commercialization (PR Newswire)
20.09.21	CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (PR Newswire)
12.08.21	CASI Pharmaceuticals Announces Second Quarter 2021 Financial Results (PR Newswire)
10.08.21	CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021 (PR Newswire)
10.06.21	CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma (PR Newswire)
01.06.21	Experten sehen bei CASI Pharmaceuticals-Aktie Potenzial (finanzen.net)
12.05.21	Ausblick: CASI Pharmaceuticals vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
30.10.18	CASI Turning Heads, GEN On Watch, MRKR For The Long Haul (RTTNews)
24.10.18	CORV Is Back, SENS' Eversense Gets Aetna Coverage, ACRX Nears FDA Decision Day (RTTNews)
29.05.18	CASI Pharmaceuticals To Present At The BIO International Convention (PR Newswire)
15.05.18	CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results (PR Newswire)
03.05.18	NVIV Inspired By Data, COOL Is Hot, OCX Braces For Busy Year, ARCT Turns Heads (RTTNews)
05.04.18	CASI Pharmaceuticals Provides Update On EVOMELA® (PR Newswire)
04.04.18	CASI Makes Case For Hope, MYND On Track, URGN Sprints, No Stopping INNT (RTTNews)
03.04.18	CASI Pharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Conference (PR Newswire)
29.03.18	CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results (PR Newswire)
21.03.18	ZEAL Displays Vigor, MDWD Getting Healed, VERU Up 80% YTD (RTTNews)
09.02.18	CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference (PR Newswire)
26.01.18	CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz) (PR Newswire)
01.12.17	CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer SymposiumTM (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC) (PR Newswire)
14.11.17	CASI Pharmaceuticals Reports Third Quarter 2017 Financial Results (PR Newswire)
28.09.17	New Research Shows Cutting New Jersey's Electric Emissions by Half Is Achievable, Affordable by 2030, Says ReThink Energy NJ (PR Newswire)
07.09.17	CASI Provides Pipeline Development Update (PR Newswire)
06.09.17	CASI Pharmaceuticals To Present At The Annual Rodman & Renshaw Global Investment Conference (PR Newswire)
14.08.17	CASI Pharmaceuticals Reports Second Quarter 2017 Financial Results (PR Newswire)
25.07.17	Arlington Asset Investment Corp. Reports Second Quarter 2017 Financial Results (PR Newswire)
18.05.17	CASI Pharmaceuticals Announces Abstract On ENMD-2076 In Clear Cell Ovarian Cancer (PR Newswire)
15.05.17	CASI Pharmaceuticals Reports First Quarter 2017 Financial Results (PR Newswire)
17.04.17	FDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move (RTTNews)
14.04.17	CASI Pharmaceuticals Reports On Enrollment Status Of ENMD-2076 Phase 2 Study In Triple-Negative Breast Cancer (PR Newswire)
28.03.17	CASI Pharmaceuticals Announces Poster Presentations At AACR Annual Meeting (PR Newswire)
05.12.16	CASI Pharmaceuticals' Import Drug Registration Application For EVOMELA® Accepted For Review By CFDA (PR Newswire)
17.08.16	OGXI Disappoints, CHMA Hands Out Pink Slips Again, No Issues For ANTH's Solution (RTTNews)
15.10.15	Shareholder Ups Stake In AFMD, Sweet Tidings From DXCM, PFE Snubbed, LLY Beams (RTTNews)
17.12.14	CASI Pharma Granted Type C Meeting With FDA For ENMD-2076 In FLC - Quick Facts (RTTNews)
18.09.14	CASI Pharma Gets Exclusive Rights To Certain Spectrum Pharma's Drugs (RTTNews)
07.07.14	CASI Pharma's ENMD-2076 Gets Orphan Drug Designation To Treat HCC - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	510.00	3.09 %	K V
UBS Group	29.96	1.97 %	K V
Zurich Insur Gr	537.60	1.55 %	K V
Logitech Intl	80.34	1.47 %	K V
Swiss Life Hldg	717.00	1.36 %	K V
Kuehne+Nagel Int	200.90	0.45 %	K V
Swisscom	509.00	0.30 %	K V
Alcon	75.84	0.18 %	K V
Nestle	73.66	-0.67 %	K V
CieFinRichemont	139.05	-0.82 %	K V

Nachrichten zu CASI Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten